ANR, or Accelerated Neuro-Regulation, is a medical procedure designed to treat opioid addiction by detoxing patients while they’re under deep sedation. Developed in 1997 by Israeli physician Dr. Andre Waismann, the treatment aims to compress the worst of opioid withdrawal into a period when the patient is unconscious and unable to feel it. It’s performed in an intensive care setting and typically takes a single hospital stay, making it one of the faster approaches to opioid detox compared to weeks or months of traditional tapering.
How ANR Works
The core idea behind ANR is that long-term opioid use creates extra opioid receptors in the brain. These additional receptors are what drive cravings and make withdrawal so punishing. During the procedure, a patient is placed under general anesthesia in an ICU, and doctors administer medications that block opioid receptors throughout the body. This forces the brain into rapid withdrawal, but because the patient is deeply sedated, they don’t experience the pain, nausea, and psychological distress that normally accompany the process.
Waismann originally used a technique called Ultra Rapid Opiate Detoxification (UROD) starting in 1993. By 1997, he had refined the approach and renamed it Accelerated Neuro-Regulation to reflect a broader goal: not just flushing opioids from the system, but resetting the brain’s receptor balance so that cravings are reduced after the patient wakes up.
What the Procedure Looks Like
ANR is not an outpatient visit. The treatment happens in a hospital with full ICU monitoring, which means heart rate, blood pressure, oxygen levels, and breathing are tracked continuously. Patients are under general anesthesia for several hours while the receptor-blocking medications do their work. After waking, most patients stay in the hospital for observation, though the total stay is typically measured in days rather than weeks.
Recovery after the procedure isn’t painless. Common aftereffects mirror a milder version of opioid withdrawal and can include headaches, nausea, vomiting, abdominal cramps, difficulty sleeping, anxiety, joint and muscle pain, and low energy. These symptoms are reported by more than 10% of patients receiving receptor-blocking medications. Less common side effects include loss of appetite, dizziness, irritability, skin rash, and chills. Most of these resolve within the first few days to weeks.
How Effective Is ANR?
The evidence on ANR and similar ultra-rapid detox procedures is limited, and the numbers that do exist come with caveats. One study of 424 patients who underwent ultra-rapid opioid detoxification found that 400 completed the program. Of those, about 76% were considered successful, meaning they did not relapse during follow-up. The relapse rate was 14% at the one-month mark and climbed to roughly 24% by six months.
Those numbers sound promising, but context matters. “Success” in rapid detox studies often means the patient completed detox and remained abstinent during a specific follow-up window. Long-term outcomes beyond six months are less well-documented, and the study did not compare results against other standard treatments like medication-assisted therapy with buprenorphine or methadone, which have decades of research supporting their effectiveness. Rapid detox, including ANR, remains controversial in the addiction medicine community partly because large, controlled trials comparing it head-to-head with established treatments are scarce.
Who Can and Can’t Get ANR
ANR involves general anesthesia and aggressive receptor blockade, so not everyone is a candidate. People with significant liver disease need careful evaluation because the receptor-blocking medications used during and after the procedure are processed by the liver, and impaired liver function changes how the body handles these drugs. The same caution applies to people with kidney problems, since the medications are primarily eliminated through urine.
The procedure has not been studied in patients under 18, so it’s not offered to minors. Pregnant women face additional risks: the receptor-blocking medications used in ANR are classified in a category where harm to a developing fetus can’t be ruled out, and animal studies have shown adverse effects on reproduction. Women who are breastfeeding face a similar dilemma, since these medications do pass into breast milk.
Patients also need to be fully clear of opioids before the procedure can safely begin. If someone is still in active withdrawal or has opioids in their system, the treatment carries a higher risk of dangerous complications. A challenge test with a short-acting blocker is typically performed beforehand to confirm the patient is ready.
Cost and Insurance
ANR is expensive. The procedure itself costs $21,500, and when you factor in accommodation for patients traveling from out of state, the total typically reaches around $22,000. That’s a significant financial commitment, especially because ANR is currently classified as an elective procedure. Health insurance plans and government programs do not cover it.
For comparison, standard medication-assisted treatments for opioid addiction are widely covered by insurance and cost a fraction of that amount on a monthly basis, though they require ongoing commitment over months or years. The appeal of ANR for some patients is the idea of a single, definitive procedure rather than long-term maintenance therapy, but the out-of-pocket cost puts it out of reach for many people.
Important Considerations After Treatment
One critical risk applies to anyone who completes any form of rapid detox, including ANR. Once your body has been cleared of opioids and your receptors are no longer accustomed to the drug, your tolerance drops dramatically. If you relapse and use the same dose you were taking before treatment, the risk of fatal overdose is significantly higher than it was before detox. This loss of tolerance is one of the most dangerous periods for anyone recovering from opioid dependence.
Patients who undergo ANR are also typically placed on a long-acting receptor blocker after the procedure to help prevent relapse. This medication requires ongoing monitoring, particularly for mood changes. Depression and suicidal thoughts have been flagged as symptoms to watch for in patients taking these medications, so follow-up mental health support is an important part of the recovery process.